SB-269970 (hydrochloride) – 25 mg

Brand:
Cayman
CAS:
261901-57-9
Storage:
-20
UN-No:
Non-Hazardous - /

The transduction of neurobehavioral effects by serotonin (5-hydroxy tryptamine; 5-HT) is mediated by at least seven major 5-HT receptor subtypes. SB-269970 is a potent 5-HT7A antagonist (pKi = 8.9) that demonstrates >50-fold binding selectivity over 5-HT5A and >250-fold selectivity over 5-HT1, 5-HT2, 5-HT4, 5-HT6, adrenergic α1, dopamine D2, and dopamine D3 receptors.{27806} It is also reported to block adrenergic α2 receptors in guinea pig vas deferens.{27807} SB-269970 has been used to target the 5-HT7 receptor in the study of schizophrenia-like cognitive deficits.{27808}  

 

Out of stock

SKU: - Category:

Description

A potent 5-HT7A antagonist (pKi = 8.9) that demonstrates >50-fold binding selectivity over 5-HT5A and >250-fold selectivity over 5-HT1, 5-HT2, 5-HT4, 5-HT6, adrenergic α1, dopamine D2, and dopamine D3 receptors


Formal name: 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]-phenol, monohydrochloride

Synonyms: 

Molecular weight: 389

CAS: 261901-57-9

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Behavioral Neuroscience|Schizophrenia & Psychosis